Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera Dose Finding in Anemic NSCLC Patients
NCT00327535Phase 2Completed
- Sponsor
- Roche
- Start
- May 2006
- Primary completion
- May 2007
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 15
01
Overview
A Phase 2 trial of methoxy polyethylene glycol-epoetin beta in anemia, sponsored by Roche. Started May 2006; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00327535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327535.